Skip to main content
Alexander Philipovskiy, MD, Oncology, Lake Mary, FL

AlexanderPhilipovskiyMDMD., PhD(He/Him)

Oncology Lake Mary, FL

Breast Cancer, Gastrointestinal Cancer

Associate Director of Drug Development Programm

Dr. Philipovskiy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Philipovskiy's full profile

Already have an account?

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Westchester Medical Center
    Westchester Medical CenterResidency, Internal Medicine, 2010 - 2013
  • Odessa Medical University
    Odessa Medical UniversityClass of 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2024
  • NY State Medical License
    NY State Medical License 2015 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Incorporating Bortezomib in the Management of Plasmablastic Lymphoma.  
    Umeanaeto O, Gamboa J, Diaz J, Hakim MN, Corral J, Philipovskiy A, Gaur S, Anticancer Research, 9/1/2019
  • Efficacy of Neoadjuvant Versus Adjuvant Chemotherapy in Hispanic/Latino (H/L) Women With Local or Locally Advanced Triple-negative Breast Cancer (TNBC).  
    Philipovskiy A, Corral J, Dwivedi KA, Heydarian R, Gaur S., In vivo, 6/1/2019

Abstracts/Posters

  • Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border
    Alexander Philipovskiy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Outcomes of Hispanic/Latino women with triple-negative breast cancer who achieve a complete pathologic response after neoadjuvant chemotherapy. 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

  • TTUHSC El Paso Assistant Professor Elected Regional Chair-Elect for International Research Organization
    TTUHSC El Paso Assistant Professor Elected Regional Chair-Elect for International Research OrganizationAugust 12th, 2020